Verona Pharma (VRNA) P/E Ratio
P/E Ratio as of Jun 13, 2025: -45.24
Average-39.68
Median-40.53
Minimum-45.38
Maximum-34.99
-45.24
Past Month-11.12 (32.59%)
The P/E ratio for Verona Pharma (VRNA) is -45.24 as of Jun 13, 2025. This represents a increase of 90.64% compared to its 12-month average P/E ratio of -23.73. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Verona Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Verona Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Verona Pharma to industry peers.
Verona Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Verona Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Verona Pharma to industry peers.
Verona Pharma (VRNA) P/E Ratio Insights
See Verona Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Verona Pharma (VRNA)
Order type
Buy in
Order amount
Est. shares
0 shares
Verona Pharma (VRNA) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $84.10 | -41.26 |
| May 1, 2025 | $72.26 | -35.45 |
| Apr 1, 2025 | $58.54 | -27.04 |
| Mar 3, 2025 | $65.97 | -30.48 |
| Feb 3, 2025 | $58.98 | -30.43 |
| Jan 2, 2025 | $48.20 | -24.87 |
Verona Pharma (VRNA) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -45.24 | +88.81% |
| 2024 | -23.96 | -21.49% |
| 2023 | -30.52 | +53.83% |
| 2022 | -19.84 | +177.87% |
| 2021 | -7.14 | +186.75% |
| 2020 | -2.49 | — |
FAQs About Verona Pharma (VRNA) P/E ratio
The latest P/E ratio of Verona Pharma (VRNA) is -45.24, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Verona Pharma’s last 12-month average P/E ratio is -23.73, compared to its current P/E ratio of -45.24. This reflects a increase of 90.64%.
Verona Pharma’s current P/E ratio of -45.24 is higher than its last 12-month average P/E of -23.73. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Verona Pharma’s average P/E ratio over the last 3 years is -21.11. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Verona Pharma’s average P/E ratio over the last 5 years is -13.9. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.